Keywords
Last Name

Timothy P. Cooley, MD

TitleAssociate Professor
InstitutionBoston University School of Medicine
DepartmentMedicine
DivisionHematology & Medical Oncology
Address820 Harrison Ave
Boston MA 02118
Phone(617) 638-7520
ORCID ORCID Icon0000-0002-3373-1569
Other Positions
TitleActive Staff Hospital Privileges
InstitutionBoston Medical Center
DepartmentMedicine

 Research Expertise & Professional Interests
My areas of clinical specialty include lung cancer, head and neck cancer and the care of HIV infected people with cancer. My research interests are in clinical trials in hematology/oncology.

 Self-Described Keywords
  • AIDS
  • Cancer Clinical Trials
  • Head and neck cancer
  • Lung cancer
 Publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Unger JM, Hershman DL, Arnold KB, Loomba R, Chugh R, Hwang JP, O'Rourke MA, Bhadkamkar NA, Wang LX, Siegel AB, Cooley TP, Berenberg JL, Bridges BB, Ramsey SD. Stepwise development of a cancer care delivery research study to evaluate the prevalence of virus infections in cancer patients. Future Oncol. 2016 May; 12(10):1219-31. PMID: 26952901.
    View in: PubMed
  2. Shah BA, Qureshi MM, Jalisi S, Grillone G, Salama A, Cooley T, Zaner K, Sakai O, Truong MT. Analysis of decision making at a multidisciplinary head and neck tumor board incorporating evidence-based National Cancer Comprehensive Network (NCCN) guidelines. Pract Radiat Oncol. 2016 Jul-Aug; 6(4):248-54. PMID: 26777060.
    View in: PubMed
  3. Castillo JJ, Bower M, Brühlmann J, Novak U, Furrer H, Tanaka PY, Besson C, Montoto S, Cwynarski K, Abramson JS, Dalia S, Bibas M, Connors JM, Furman M, Nguyen ML, Cooley TP, Beltran BE, Collins JA, Vose JM, Xicoy B, Ribera JM. Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective study. Cancer. 2015 Feb 1; 121(3):423-31. PMID: 25251326.
    View in: PubMed
  4. Qureshi MM, Romesser PB, Jalisi S, Zaner KS, Cooley TP, Grillone G, Kachnic LA, Truong MT. The influence of limited English proficiency on outcome in patients treated with radiotherapy for head and neck cancer. Patient Educ Couns. 2014 Nov; 97(2):276-82. PMID: 25190640.
    View in: PubMed
  5. Yu J, Cooley T, Truong MT, Mercier G, Subramaniam RM. Head and neck squamous cell cancer (stages III and IV) induction chemotherapy assessment: value of FDG volumetric imaging parameters. J Med Imaging Radiat Oncol. 2014 Feb; 58(1):18-24. PMID: 24529051.
    View in: PubMed
  6. Boehmer U, Cooley TP, Clark MA. Cancer and men who have sex with men: a systematic review. Lancet Oncol. 2012 Dec; 13(12):e545-53. PMID: 23182195.
    View in: PubMed
  7. Levine AM, Noy A, Lee JY, Tam W, Ramos JC, Henry DH, Parekh S, Reid EG, Mitsuyasu R, Cooley T, Dezube BJ, Ratner L, Cesarman E, Tulpule A. Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047. J Clin Oncol. 2013 Jan 1; 31(1):58-64. PMID: 23169503.
    View in: PubMed
  8. Agarwal A, Mehta A, Logeswaran P, Cooley TP, Subramaniam RM. Radiology quiz case 2. Docetaxel (Taxotere)-induced photosensitivity. Arch Otolaryngol Head Neck Surg. 2012 Sep; 138(9):869-70. PMID: 22986725.
    View in: PubMed
  9. Bayraktar UD, Ramos JC, Petrich A, Gupta N, Lensing S, Moore PC, Reid EG, Aboulafia DM, Ratner L, Mitsuyasu R, Cooley T, Henry DH, Barr P, Noy A. Outcome of patients with relapsed/refractory acquired immune deficiency syndrome-related lymphoma diagnosed 1999-2008 and treated with curative intent in the AIDS Malignancy Consortium. Leuk Lymphoma. 2012 Dec; 53(12):2383-9. PMID: 22642936.
    View in: PubMed
  10. Davison JM, Subramaniam RM, Surasi DS, Cooley T, Mercier G, Peller PJ. FDG PET/CT in patients with HIV. AJR Am J Roentgenol. 2011 Aug; 197(2):284-94. PMID: 21785073.
    View in: PubMed
  11. D'Jaen GA, Pantanowitz L, Bower M, Buskin S, Neil N, Greco EM, Cooley TP, Henry D, Stem J, Dezube BJ, Stebbing J, Aboulafia DM. Human immunodeficiency virus-associated primary lung cancer in the era of highly active antiretroviral therapy: a multi-institutional collaboration. Clin Lung Cancer. 2010 Nov 1; 11(6):396-404. PMID: 21062730.
    View in: PubMed
  12. Gaughan EM, Dezube BJ, Bower M, Aboulafia DM, Bohac G, Cooley TP, Pantanowitz L. HIV-associated bladder cancer: a case series evaluating difficulties in diagnosis and management. BMC Urol. 2009; 9:10. PMID: 19719844.
    View in: PubMed
  13. Pantanowitz L, Bohac G, Cooley TP, Aboulafia D, Dezube BJ. Human immunodeficiency virus-associated prostate cancer: clinicopathological findings and outcome in a multi-institutional study. BJU Int. 2008 Jun; 101(12):1519-23. PMID: 18384640.
    View in: PubMed
  14. Cooley T, Henry D, Tonda M, Sun S, O'Connell M, Rackoff W. A randomized, double-blind study of pegylated liposomal doxorubicin for the treatment of AIDS-related Kaposi's sarcoma. Oncologist. 2007 Jan; 12(1):114-23. PMID: 17227906.
    View in: PubMed
  15. Amara S, Dezube BJ, Cooley TP, Pantanowitz L, Aboulafia DM. HIV-associated monoclonal gammopathy: a retrospective analysis of 25 patients. Clin Infect Dis. 2006 Nov 1; 43(9):1198-205. PMID: 17029142.
    View in: PubMed
  16. Mullins C, Eisen G, Popper S, Dieng Sarr A, Sankale JL, Berger JJ, Wright SB, Chang HR, Coste G, Cooley TP, Rice P, Skolnik PR, Sullivan M, Kanki PJ. Highly active antiretroviral therapy and viral response in HIV type 2 infection. Clin Infect Dis. 2004 Jun 15; 38(12):1771-9. PMID: 15227626.
    View in: PubMed
  17. Cooley TP. Non-AIDS-defining cancer in HIV-infected people. Hematol Oncol Clin North Am. 2003 Jun; 17(3):889-99. PMID: 12852661.
    View in: PubMed
  18. Modest GA, Cooley TP, Zacks JF. HIV and refractory anemia with excess blasts (RAEB). Am J Hematol. 2002 Aug; 70(4):318-9. PMID: 12210814.
    View in: PubMed
  19. Evans SR, Krown SE, Testa MA, Cooley TP, Von Roenn JH. Phase II evaluation of low-dose oral etoposide for the treatment of relapsed or progressive AIDS-related Kaposi's sarcoma: an AIDS Clinical Trials Group clinical study. J Clin Oncol. 2002 Aug 1; 20(15):3236-41. PMID: 12149296.
    View in: PubMed
  20. Miles SA, Dezube BJ, Lee JY, Krown SE, Fletcher MA, Saville MW, Kaplan L, Groopman J, Scadden DT, Cooley T, Von Roenn J, Friedman-Kien A. Antitumor activity of oral 9-cis-retinoic acid in HIV-associated Kaposi's sarcoma. AIDS. 2002 Feb 15; 16(3):421-9. PMID: 11834954.
    View in: PubMed
  21. Cianfrocca M, Cooley TP, Lee JY, Rudek MA, Scadden DT, Ratner L, Pluda JM, Figg WD, Krown SE, Dezube BJ. Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium study. J Clin Oncol. 2002 Jan 1; 20(1):153-9. PMID: 11773164.
    View in: PubMed
  22. Borges VF, Keating JT, Nasser IA, Cooley TP, Greenberg HL, Dezube BJ. Clinicopathologic characterization of squamous-cell carcinoma arising from pilonidal disease in association with condylomata acuminatum in HIV-infected patients: report of two cases. Dis Colon Rectum. 2001 Dec; 44(12):1873-7. PMID: 11742179.
    View in: PubMed
  23. Akpek G, Lee SM, Gagnon DR, Cooley TP, Wright DG. Bone marrow aspiration, biopsy, and culture in the evaluation of HIV-infected patients for invasive mycobacteria and histoplasma infections. Am J Hematol. 2001 Jun; 67(2):100-6. PMID: 11343381.
    View in: PubMed
  24. Squires KE, Gulick R, Tebas P, Santana J, Mulanovich V, Clark R, Yangco B, Marlowe SI, Wright D, Cohen C, Cooley T, Mauney J, Uffelman K, Schoellkopf N, Grosso R, Stevens M. A comparison of stavudine plus lamivudine versus zidovudine plus lamivudine in combination with indinavir in antiretroviral naive individuals with HIV infection: selection of thymidine analog regimen therapy (START I). AIDS. 2000 Jul 28; 14(11):1591-600. PMID: 10983646.
    View in: PubMed
  25. Lee VW, Antonacci V, Tilak S, Fuller JD, Cooley TP. Intracranial mass lesions: sequential thallium and gallium scintigraphy in patients with AIDS. Radiology. 1999 May; 211(2):507-12. PMID: 10228535.
    View in: PubMed
  26. Khurshid A, Joseph JT, Rachlin J, Cooley TP, Kleefield J, Dezube BJ. Meningioma in four patients with human immunodeficiency virus infection. Mayo Clin Proc. 1999 Mar; 74(3):253-7. PMID: 10089994.
    View in: PubMed
  27. Dezube BJ, Von Roenn JH, Holden-Wiltse J, Cheung TW, Remick SC, Cooley TP, Moore J, Sommadossi JP, Shriver SL, Suckow CW, Gill PS. Fumagillin analog in the treatment of Kaposi's sarcoma: a phase I AIDS Clinical Trial Group study. AIDS Clinical Trial Group No. 215 Team. J Clin Oncol. 1998 Apr; 16(4):1444-9. PMID: 9552050.
    View in: PubMed
  28. Kaplan LD, Straus DJ, Testa MA, Von Roenn J, Dezube BJ, Cooley TP, Herndier B, Northfelt DW, Huang J, Tulpule A, Levine AM. Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. N Engl J Med. 1997 Jun 5; 336(23):1641-8. PMID: 9171066.
    View in: PubMed
  29. Cooley TP, Hirschhorn LR, O'Keane JC. Kaposi's sarcoma in women with AIDS. AIDS. 1996 Sep; 10(11):1221-5. PMID: 8883583.
    View in: PubMed
  30. Pluda JM, Cooley TP, Montaner JS, Shay LE, Reinhalter NE, Warthan SN, Ruedy J, Hirst HM, Vicary CA, Quinn JB, et al. A phase I/II study of 2'-deoxy-3'-thiacytidine (lamivudine) in patients with advanced human immunodeficiency virus infection. J Infect Dis. 1995 Jun; 171(6):1438-47. PMID: 7769277.
    View in: PubMed
  31. Wainberg MA, Salomon H, Gu Z, Montaner JS, Cooley TP, McCaffrey R, Ruedy J, Hirst HM, Cammack N, Cameron J, et al. Development of HIV-1 resistance to (-)2'-deoxy-3'-thiacytidine in patients with AIDS or advanced AIDS-related complex. AIDS. 1995 Apr; 9(4):351-7. PMID: 7540846.
    View in: PubMed
  32. Lee VW, Cooley TP, Fuller JD, Ward RJ, Farber HW. Pulmonary mycobacterial infections in AIDS: characteristic pattern of thallium and gallium scan mismatch. Radiology. 1994 Nov; 193(2):389-92. PMID: 7972748.
    View in: PubMed
  33. Eron JJ, Chow YK, Caliendo AM, Videler J, Devore KM, Cooley TP, Liebman HA, Kaplan JC, Hirsch MS, D'Aquila RT. pol mutations conferring zidovudine and didanosine resistance with different effects in vitro yield multiply resistant human immunodeficiency virus type 1 isolates in vivo. Antimicrob Agents Chemother. 1993 Jul; 37(7):1480-7. PMID: 7689822.
    View in: PubMed
  34. McLaren C, Rozencweig M, Beltangady M, Nicaise C, Yarchoan R, Dolin R, Allan JD, Cooley TP, Seidlin M, Smaldone LF. Longitudinal analysis of responses to oral didanosine therapy following zidovudine therapy in advanced infection with human immunodeficiency virus. Clin Infect Dis. 1993 Feb; 16 Suppl 1:S32-9. PMID: 8425018.
    View in: PubMed
  35. Liebman HA, Cooley TP. Didanosine in the treatment of AIDS and AIDS-related complex: a critical appraisal of the dose and frequency of administration. Clin Infect Dis. 1993 Feb; 16 Suppl 1:S52-8. PMID: 8093847.
    View in: PubMed
  36. Beltangady M, Knupp CA, Gustafson N, Barbhaiya RH, Dolin R, Seidlin M, Cooley TP, Rozencweig M. Relation between plasma concentrations of didanosine and markers of antiviral efficacy in adults with AIDS or AIDS-related complex. Clin Infect Dis. 1993 Feb; 16 Suppl 1:S26-31. PMID: 8093845.
    View in: PubMed
  37. Schacter LP, Rozencweig M, Beltangady M, Allan JD, Canetta R, Cooley TP, Dolin R, Kelley S, Lambert J, Liebman HA, et al. Effects of therapy with didanosine on hematologic parameters in patients with advanced human immunodeficiency virus disease. Blood. 1992 Dec 15; 80(12):2969-76. PMID: 1467512.
    View in: PubMed
  38. Drusano GL, Yuen GJ, Morse G, Cooley TP, Seidlin M, Lambert JS, Liebman HA, Valentine FT, Dolin R. Impact of bioavailability on determination of the maximal tolerated dose of 2',3'-dideoxyinosine in phase I trials. Antimicrob Agents Chemother. 1992 Jun; 36(6):1280-3. PMID: 1416828.
    View in: PubMed
  39. Lai KK, Gang DL, Zawacki JK, Cooley TP. Fulminant hepatic failure associated with 2',3'-dideoxyinosine (ddI). Ann Intern Med. 1991 Aug 15; 115(4):283-4. PMID: 1906693.
    View in: PubMed
  40. Lee VW, Fuller JD, O'Brien MJ, Parker DR, Cooley TP, Liebman HA. Pulmonary Kaposi sarcoma in patients with AIDS: scintigraphic diagnosis with sequential thallium and gallium scanning. Radiology. 1991 Aug; 180(2):409-12. PMID: 2068302.
    View in: PubMed
  41. Cooley TP, Kunches LM, Saunders CA, Perkins CJ, Kelley SL, McLaren C, McCaffrey RP, Liebman HA. Treatment of AIDS and AIDS-related complex with 2',3'-dideoxyinosine given once daily. Rev Infect Dis. 1990 Jul-Aug; 12 Suppl 5:S552-60. PMID: 1974727.
    View in: PubMed
  42. Cooley TP, Kunches LM, Saunders CA, Ritter JK, Perkins CJ, McLaren C, McCaffrey RP, Liebman HA. Once-daily administration of 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Results of a Phase I trial. N Engl J Med. 1990 May 10; 322(19):1340-5. PMID: 2139174.
    View in: PubMed
  43. Craven DE, Liebman HA, Fuller J, Hagerty C, Cooley TP, Saunders CA, Steger KA, Libman H. AIDS in intravenous drug users: issues related to enrollment in clinical trials. J Acquir Immune Defic Syndr. 1990; 3 Suppl 2:S45-50. PMID: 2231302.
    View in: PubMed
  44. Lee VW, Rosen MP, Baum A, Cohen SE, Cooley TP, Liebman HA. AIDS-related Kaposi sarcoma: findings on thallium-201 scintigraphy. AJR Am J Roentgenol. 1988 Dec; 151(6):1233-5. PMID: 3263778.
    View in: PubMed
  45. Hesketh PJ, Cooley TP, Finkel HE, Wright J, Hesketh AM. Treatment of advanced non-small cell lung cancer with cisplatin, 5-fluorouracil, and mitomycin C. Cancer. 1988 Oct 15; 62(8):1466-70. PMID: 2844381.
    View in: PubMed
Timothy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
BU Co-Authors
_
Similar BU People
_
Same Department